Europe Respiratory Disease Testing Market Databank

Europe Respiratory Disease Testing Market Databank

The Respiratory Disease Testing market was valued at $10.4 Million in 2020, and is projected to reach $19.5 Million by 2029 growing at a CAGR of 7.37% from 2021 to 2029. Imaging Tests segment is expected to be the highest contributor to this market, with $4.4 Million in 2020, and is anticipated to reach $8.2 Million by 2029, registering a CAGR of 7.34%. Mechanical Tests segment is anticipated to reach $6.3 Million by 2029 with the highest CAGR of 7.49%. Imaging Tests and Mechanical Tests segments collectively expected to account for about 74.0% share of the Respiratory Disease Testing market in 2020, with the former constituting around 42.0% share. Mechanical Tests and Imaging Tests segments are expected to witness significant growth rates at a CAGR of 7.49% and 7.34% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 74.0% in the overall Respiratory Disease Testing market in 2020, and is anticipated to reach 74.2% by 2029.


1. GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY PRODUCT
1.1. OVERVIEW
1.2. MECHANICAL TESTS
1.2.1 MECHANICAL TESTS MARKET, BY REGION
1.2.1.1 North America Mechanical Tests Market, By Country
1.2.1.2 Europe Mechanical Tests Market, By Country
1.2.1.3 Asia-Pacific Mechanical Tests Market, By Country
1.2.1.4 Rest of World Mechanical Tests Market, By Country
1.3. IMAGING TESTS
1.3.1 IMAGING TESTS MARKET, BY REGION
1.3.1.1 North America Imaging Tests Market, By Country
1.3.1.2 Europe Imaging Tests Market, By Country
1.3.1.3 Asia-Pacific Imaging Tests Market, By Country
1.3.1.4 Rest of World Imaging Tests Market, By Country
1.4. IN-VITRO DIAGNOSTICS TESTS
1.4.1 IN-VITRO DIAGNOSTICS TESTS MARKET, BY REGION
1.4.1.1 North America In-vitro Diagnostics Tests Market, By Country
1.4.1.2 Europe In-vitro Diagnostics Tests Market, By Country
1.4.1.3 Asia-Pacific In-vitro Diagnostics Tests Market, By Country
1.4.1.4 Rest of World In-vitro Diagnostics Tests Market, By Country
2. GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY APPLICATION
2.1. OVERVIEW
2.2. CHRONIC OBSTRUCTIVE PULMONARY DISEASE
2.2.1 CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET, BY REGION
2.2.1.1 North America Chronic Obstructive Pulmonary Disease Market, By Country
2.2.1.2 Europe Chronic Obstructive Pulmonary Disease Market, By Country
2.2.1.3 Asia-Pacific Chronic Obstructive Pulmonary Disease Market, By Country
2.2.1.4 Rest of World Chronic Obstructive Pulmonary Disease Market, By Country
2.3. LUNG CANCER
2.3.1 LUNG CANCER MARKET, BY REGION
2.3.1.1 North America Lung Cancer Market, By Country
2.3.1.2 Europe Lung Cancer Market, By Country
2.3.1.3 Asia-Pacific Lung Cancer Market, By Country
2.3.1.4 Rest of World Lung Cancer Market, By Country
2.4. ASTHMA
2.4.1 ASTHMA MARKET, BY REGION
2.4.1.1 North America Asthma Market, By Country
2.4.1.2 Europe Asthma Market, By Country
2.4.1.3 Asia-Pacific Asthma Market, By Country
2.4.1.4 Rest of World Asthma Market, By Country
2.5. TUBERCULOSIS
2.5.1 TUBERCULOSIS MARKET, BY REGION
2.5.1.1 North America Tuberculosis Market, By Country
2.5.1.2 Europe Tuberculosis Market, By Country
2.5.1.3 Asia-Pacific Tuberculosis Market, By Country
2.5.1.4 Rest of World Tuberculosis Market, By Country
2.6. OTHER APPLICATIONS
2.6.1 OTHER APPLICATIONS MARKET, BY REGION
2.6.1.1 North America Other Applications Market, By Country
2.6.1.2 Europe Other Applications Market, By Country
2.6.1.3 Asia-Pacific Other Applications Market, By Country
2.6.1.4 Rest of World Other Applications Market, By Country
3. GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY END USE
3.1. OVERVIEW
3.2. DIAGNOSTIC CENTRES
3.2.1 DIAGNOSTIC CENTRES MARKET, BY REGION
3.2.1.1 North America Diagnostic Centres Market, By Country
3.2.1.2 Europe Diagnostic Centres Market, By Country
3.2.1.3 Asia-Pacific Diagnostic Centres Market, By Country
3.2.1.4 Rest of World Diagnostic Centres Market, By Country
3.3. HOSPITALS
3.3.1 HOSPITALS MARKET, BY REGION
3.3.1.1 North America Hospitals Market, By Country
3.3.1.2 Europe Hospitals Market, By Country
3.3.1.3 Asia-Pacific Hospitals Market, By Country
3.3.1.4 Rest of World Hospitals Market, By Country
3.4. CLINICS
3.4.1 CLINICS MARKET, BY REGION
3.4.1.1 North America Clinics Market, By Country
3.4.1.2 Europe Clinics Market, By Country
3.4.1.3 Asia-Pacific Clinics Market, By Country
3.4.1.4 Rest of World Clinics Market, By Country
3.5. OTHER END USES
3.5.1 OTHER END USES MARKET, BY REGION
3.5.1.1 North America Other End uses Market, By Country
3.5.1.2 Europe Other End uses Market, By Country
3.5.1.3 Asia-Pacific Other End uses Market, By Country
3.5.1.4 Rest of World Other End uses Market, By Country
4. GLOBAL RESPIRATORY DISEASE TESTING MARKET, BY REGION
4.1. OVERVIEW
4.2. EUROPE
4.2.1 EUROPE RESPIRATORY DISEASE TESTING MARKET, BY PRODUCT
4.2.2 EUROPE RESPIRATORY DISEASE TESTING MARKET, BY APPLICATION
4.2.3 EUROPE RESPIRATORY DISEASE TESTING MARKET, BY END USE
4.2.4 EUROPE RESPIRATORY DISEASE TESTING MARKET, BY COUNTRY
4.2.4.1 Germany
4.2.4.1.1 Germany Respiratory Disease Testing Market, By Product
4.2.4.1.2 Germany Respiratory Disease Testing Market, By Application
4.2.4.1.3 Germany Respiratory Disease Testing Market, By End use
4.2.4.2 France
4.2.4.2.1 France Respiratory Disease Testing Market, By Product
4.2.4.2.2 France Respiratory Disease Testing Market, By Application
4.2.4.2.3 France Respiratory Disease Testing Market, By End use
4.2.4.3 UK
4.2.4.3.1 UK Respiratory Disease Testing Market, By Product
4.2.4.3.2 UK Respiratory Disease Testing Market, By Application
4.2.4.3.3 UK Respiratory Disease Testing Market, By End use
4.2.4.4 Italy
4.2.4.4.1 Italy Respiratory Disease Testing Market, By Product
4.2.4.4.2 Italy Respiratory Disease Testing Market, By Application
4.2.4.4.3 Italy Respiratory Disease Testing Market, By End use
4.2.4.5 Spain
4.2.4.5.1 Spain Respiratory Disease Testing Market, By Product
4.2.4.5.2 Spain Respiratory Disease Testing Market, By Application
4.2.4.5.3 Spain Respiratory Disease Testing Market, By End use
4.2.4.6 Russia
4.2.4.6.1 Russia Respiratory Disease Testing Market, By Product
4.2.4.6.2 Russia Respiratory Disease Testing Market, By Application
4.2.4.6.3 Russia Respiratory Disease Testing Market, By End use
4.2.4.7 Rest of Europe
4.2.4.7.1 Rest of Europe Respiratory Disease Testing Market, By Product
4.2.4.7.2 Rest of Europe Respiratory Disease Testing Market, By Application
4.2.4.7.3 Rest of Europe Respiratory Disease Testing Market, By End use
List of Tables
TABLE 1. GLOBAL RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
TABLE 2. MECHANICAL TESTS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 3. NORTH AMERICA MECHANICAL TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 4. EUROPE MECHANICAL TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 5. ASIA-PACIFIC MECHANICAL TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 6. REST OF WORLD MECHANICAL TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 7. IMAGING TESTS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 8. NORTH AMERICA IMAGING TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 9. EUROPE IMAGING TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 10. ASIA-PACIFIC IMAGING TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 11. REST OF WORLD IMAGING TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 12. IN-VITRO DIAGNOSTICS TESTS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 13. NORTH AMERICA IN-VITRO DIAGNOSTICS TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 14. EUROPE IN-VITRO DIAGNOSTICS TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 15. ASIA-PACIFIC IN-VITRO DIAGNOSTICS TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 16. REST OF WORLD IN-VITRO DIAGNOSTICS TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 17. GLOBAL RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
TABLE 18. CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 19. NORTH AMERICA CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 20. EUROPE CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 21. ASIA-PACIFIC CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 22. REST OF WORLD CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 23. LUNG CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 24. NORTH AMERICA LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 25. EUROPE LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 26. ASIA-PACIFIC LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 27. REST OF WORLD LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 28. ASTHMA MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 29. NORTH AMERICA ASTHMA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 30. EUROPE ASTHMA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 31. ASIA-PACIFIC ASTHMA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 32. REST OF WORLD ASTHMA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 33. TUBERCULOSIS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 34. NORTH AMERICA TUBERCULOSIS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 35. EUROPE TUBERCULOSIS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 36. ASIA-PACIFIC TUBERCULOSIS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 37. REST OF WORLD TUBERCULOSIS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 38. OTHER APPLICATIONS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 39. NORTH AMERICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 40. EUROPE OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 41. ASIA-PACIFIC OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 42. REST OF WORLD OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 43. GLOBAL RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
TABLE 44. DIAGNOSTIC CENTRES MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 45. NORTH AMERICA DIAGNOSTIC CENTRES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 46. EUROPE DIAGNOSTIC CENTRES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 47. ASIA-PACIFIC DIAGNOSTIC CENTRES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 48. REST OF WORLD DIAGNOSTIC CENTRES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 49. HOSPITALS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 50. NORTH AMERICA HOSPITALS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 51. EUROPE HOSPITALS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 52. ASIA-PACIFIC HOSPITALS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 53. REST OF WORLD HOSPITALS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 54. CLINICS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 55. NORTH AMERICA CLINICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 56. EUROPE CLINICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 57. ASIA-PACIFIC CLINICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 58. REST OF WORLD CLINICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 59. OTHER END USES MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 60. NORTH AMERICA OTHER END USES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 61. EUROPE OTHER END USES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 62. ASIA-PACIFIC OTHER END USES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 63. REST OF WORLD OTHER END USES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 64. GLOBAL RESPIRATORY DISEASE TESTING MARKET VALUE, BY REGION, 2020-2029, MILLION USD
TABLE 65. EUROPE RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
TABLE 66. EUROPE RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
TABLE 67. EUROPE RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
TABLE 68. EUROPE RESPIRATORY DISEASE TESTING MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
TABLE 69. GERMANY RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
TABLE 70. GERMANY RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
TABLE 71. GERMANY RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
TABLE 72. FRANCE RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
TABLE 73. FRANCE RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
TABLE 74. FRANCE RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
TABLE 75. UK RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
TABLE 76. UK RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
TABLE 77. UK RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
TABLE 78. ITALY RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
TABLE 79. ITALY RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
TABLE 80. ITALY RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
TABLE 81. SPAIN RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
TABLE 82. SPAIN RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
TABLE 83. SPAIN RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
TABLE 84. RUSSIA RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
TABLE 85. RUSSIA RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
TABLE 86. RUSSIA RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
TABLE 87. REST OF EUROPE RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
TABLE 88. REST OF EUROPE RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
TABLE 89. REST OF EUROPE RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
FIGURE 1. GLOBAL RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 2. MECHANICAL TESTS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 3. NORTH AMERICA MECHANICAL TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 4. EUROPE MECHANICAL TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 5. ASIA-PACIFIC MECHANICAL TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 6. REST OF WORLD MECHANICAL TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 7. IMAGING TESTS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 8. NORTH AMERICA IMAGING TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 9. EUROPE IMAGING TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 10. ASIA-PACIFIC IMAGING TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 11. REST OF WORLD IMAGING TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 12. IN-VITRO DIAGNOSTICS TESTS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 13. NORTH AMERICA IN-VITRO DIAGNOSTICS TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 14. EUROPE IN-VITRO DIAGNOSTICS TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 15. ASIA-PACIFIC IN-VITRO DIAGNOSTICS TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 16. REST OF WORLD IN-VITRO DIAGNOSTICS TESTS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 17. GLOBAL RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
FIGURE 18. CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 19. NORTH AMERICA CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 20. EUROPE CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 21. ASIA-PACIFIC CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 22. REST OF WORLD CHRONIC OBSTRUCTIVE PULMONARY DISEASE MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 23. LUNG CANCER MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 24. NORTH AMERICA LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 25. EUROPE LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 26. ASIA-PACIFIC LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 27. REST OF WORLD LUNG CANCER MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 28. ASTHMA MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 29. NORTH AMERICA ASTHMA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 30. EUROPE ASTHMA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 31. ASIA-PACIFIC ASTHMA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 32. REST OF WORLD ASTHMA MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 33. TUBERCULOSIS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 34. NORTH AMERICA TUBERCULOSIS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 35. EUROPE TUBERCULOSIS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 36. ASIA-PACIFIC TUBERCULOSIS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 37. REST OF WORLD TUBERCULOSIS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 38. OTHER APPLICATIONS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 39. NORTH AMERICA OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 40. EUROPE OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 41. ASIA-PACIFIC OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 42. REST OF WORLD OTHER APPLICATIONS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 43. GLOBAL RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
FIGURE 44. DIAGNOSTIC CENTRES MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 45. NORTH AMERICA DIAGNOSTIC CENTRES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 46. EUROPE DIAGNOSTIC CENTRES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 47. ASIA-PACIFIC DIAGNOSTIC CENTRES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 48. REST OF WORLD DIAGNOSTIC CENTRES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 49. HOSPITALS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 50. NORTH AMERICA HOSPITALS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 51. EUROPE HOSPITALS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 52. ASIA-PACIFIC HOSPITALS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 53. REST OF WORLD HOSPITALS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 54. CLINICS MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 55. NORTH AMERICA CLINICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 56. EUROPE CLINICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 57. ASIA-PACIFIC CLINICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 58. REST OF WORLD CLINICS MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 59. OTHER END USES MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 60. NORTH AMERICA OTHER END USES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 61. EUROPE OTHER END USES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 62. ASIA-PACIFIC OTHER END USES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 63. REST OF WORLD OTHER END USES MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 64. GLOBAL RESPIRATORY DISEASE TESTING MARKET VALUE, BY REGION, 2020-2029, MILLION USD
FIGURE 65. EUROPE RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 66. EUROPE RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
FIGURE 67. EUROPE RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
FIGURE 68. EUROPE RESPIRATORY DISEASE TESTING MARKET VALUE, BY COUNTRY, 2020-2029, MILLION USD
FIGURE 69. GERMANY RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 70. GERMANY RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
FIGURE 71. GERMANY RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
FIGURE 72. FRANCE RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 73. FRANCE RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
FIGURE 74. FRANCE RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
FIGURE 75. UK RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 76. UK RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
FIGURE 77. UK RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
FIGURE 78. ITALY RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 79. ITALY RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
FIGURE 80. ITALY RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
FIGURE 81. SPAIN RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 82. SPAIN RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
FIGURE 83. SPAIN RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
FIGURE 84. RUSSIA RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 85. RUSSIA RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
FIGURE 86. RUSSIA RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
FIGURE 87. REST OF EUROPE RESPIRATORY DISEASE TESTING MARKET VALUE, BY PRODUCT, 2020-2029, MILLION USD
FIGURE 88. REST OF EUROPE RESPIRATORY DISEASE TESTING MARKET VALUE, BY APPLICATION, 2020-2029, MILLION USD
FIGURE 89. REST OF EUROPE RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD
FIGURE 90. ROW COUNTRIES RESPIRATORY DISEASE TESTING MARKET VALUE, BY END USE, 2020-2029, MILLION USD

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook